Integrated bioanalytical solutions

For vaccines, Vismederi offers integrated solutions to evaluate efficacy and immunogenicity through the analysis of both humoral and cell mediated immune responses (also incorporating deep profiling of vaccine-induced immunogenicity at single cell resolution via technologies such as CyTOF), enabling a comprehensive and mechanistic understanding of immune activation. The same analytical approaches are applied to monoclonal antibodies and antiviral candidates, supporting the characterization of functionality, mechanism of action, and immune engagement. Complementing these capabilities, Vismederi provides molecular genomic technologies—such as next generation sequencing or the multiplex PCR-based platform BioFire FilmArray Torch — to support in depth characterization of viral and bacterial pathogens. These approaches allow sensitive detection, quantification, and genetic analysis, supporting strain identification, variant monitoring and evolution. This integrated framework strengthens the evaluation of drugs by linking immunological and genetic data within a unified bioanalytical platform.